全部

1·Objective To evaluate therapeutic effect of intravenous immunoglobulin (IVIG) on infant virus-associated wheezing diseases.

目的为评估静脉注射人丙种球蛋白（IVIG）治疗婴幼儿病毒相关性喘息的临床疗效。

2·Objective: To explore clinic and immunologic effect of intravenous immunoglobulin (IVIG) on children with viral myocarditis (VMC).

目的：探讨静脉丙种球蛋白(IVIG)对小儿病毒性心肌炎(VMC)的临床疗效及其免疫干预作用。

3·Intravenous immunoglobulin has been shown to be effective in the treatment of many immune-mediated diseases as an immunomodulatory agent.

静脉注射免疫球蛋白作为一种免疫调节剂可治疗多种免疫相关性疾病。

4·Objective:To observe the therapeutic effect of high dose intravenous immunoglobulin(HD IVIG) on patients with severe Guillain Barre syndrome(GBS).

目的：观察大剂量静脉滴注免疫球蛋白（HD IVIG）治疗重型格林巴利综合征（GBS）的疗效。

5·Objective To evaluate the adjunctive therapeutic effect of intravenous immunoglobulin (IVIG) therapy in the pulmonary infection after kidney transplantation.

目的探讨静脉注射大剂量免疫球蛋白在肾移植后肺部感染治疗中的辅助作用。

6·Objective: to investigate the clinical therapeutic effectiveness of intravenous immunoglobulin (IVIG) in the treatment of refractory nephritic syndrome (RNS) in children.

目的：探讨静脉注射用免疫球蛋白(IVIG)对儿童难治性肾病综合征(RNS)的临床疗效。

7·In a trial of glucocorticosteroids versus intravenous immunoglobulin (33 participants) no differences in treatment responses were encountered during a treatment period of 14 days.

在一个比较糖皮质类固醇和静脉注射免疫球蛋白﹝33位病人﹞的试验，在14天的治疗期间没有发现任何疗法间的差异。

8·ObjectiveTo study the clinical effects and possible immunological mechanism of high-dose intravenous immunoglobulin (HIVIG) in neonates with hypoxic-ischemic encephalopathy (HIE).

目的研究静脉注射大剂量免疫球蛋白(HIVIG)治疗新生儿低氧缺血性脑病(HIE)的临床疗效和免疫学机制。

9·Intravenous immunoglobulin (IVIg) has been used in clinical therapy since the end of 1970's. The clinical indications have been extended with the mechanism of IVIg known gradually.

静脉注射免疫球蛋白自二十世纪70年代末开始用于临床，随着对其作用机理认识的逐渐深入，其临床适应症扩大。

10·To introduce etiologic therapy in evidence-based medicine (EBM) practice for Guillain-Barr syndrome (GBS), mainly including plasma exchange, intravenous immunoglobulin and glucocorticoid.

介绍吉兰·巴雷综合征(GBS)病因治疗的循证医学证据，主要包括血浆置换、静脉注射免疫球蛋白、糖皮质激素。